CuraGen Corporation

Type: Company
Name: CuraGen Corporation
Nationality: United States
First reported Aug 08 2014 - Updated Aug 08 2014 - 1 reports

Celldex Therapeutics announces management changes

Celldex Therapeutics, Inc., a biopharmaceutical company, has announced three promotions in its clinical and research departments. The company has promoted Tibor Keler to executive vice president and chief scientific officer. The company has also promoted ... [Published Individual.com - Aug 08 2014]
First reported Jul 30 2014 - Updated Jul 30 2014 - 1 reports

Celldex Therapeutics Announces Senior Leadership Promotions

(GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. ( Nasdaq:CLDX ) today announced three promotions in the Company's clinical and research departments:Tibor Keler, PhD promoted to Executive Vice President and Chief Scientific Officer; Thomas Davis, MD promoted ... [Published CBS Detroit - Jul 30 2014]
First reported Jul 24 2014 - Updated Jul 24 2014 - 1 reports

Construction underway at new army training site in Branford

BRANFORD >> Crews have begun moving earth off of East Main Street at the future site of the Bridgeport Army Reserve Center, as last week a Mississippi-based construction company secured a $13.5 million contract with the U.S. Army Corps of Engin ... [Published New Haven Register - Jul 24 2014]
First reported Apr 28 2014 - Updated Apr 28 2014 - 1 reports

Connecticut Innovations Names David Wurzer Executive Vice President and Chief Investment Officer

CI veteran to oversee venture investment operations as part of CI’s senior leadership team Connecticut Innovations (CI), the leading source of financing and ongoing support for Connecticut's innovative, growing companies, today announced that David Wurzer, ... [Published PRWeb - Apr 28 2014]

Quotes

"Tom, who joined Celldex soon after we started the Company, has been integral in leading the clinical development of our programs, with five candidates in clinical studies, including two in potential registration studies. Beth, who joined us in 2009, is responsible for the execution of our development programs, expertly overseeing the coordination and successful completion of the programs, including more than 30 company- and investigator-sponsored clinical trials. The combined experience and expertise of these three leaders has and will continue to be very important to our success as we move toward commercialization."

More Content

All (4) | News (4) | Reports (0) | Blogs (0) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
Celldex Therapeutics announces management changes [Published Individual.com - Aug 08 2014]
Celldex Therapeutics Announces Senior Leadershi... [Published CBS Detroit - Jul 30 2014]
Construction underway at new army training site... [Published New Haven Register - Jul 24 2014]
Connecticut Innovations Names David Wurzer Exec... [Published PRWeb - Apr 28 2014]
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.